Aminosidine plus sodium stibogluconate for the treatment of Indian kala-azar: A randomized dose-finding clinical trial

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 89, Issue 2, 1995, Pages 219-223

  Thakur, Mrudula ^a   Olliaro, P ^a,b   Dolfi, L ^c  

^a PATNA MEDICAL COLLEGE AND HOSPITAL   (India)

^b PFIZER INC   (United States)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Aminosidine plus sodium stibogluconate; India; Leishmania donovani; Treatment; Visceral leishmaniasis

Indexed keywords

PAROMOMYCIN; STIBOGLUCONATE SODIUM;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; HUMAN; INDIA; INTRAMUSCULAR DRUG ADMINISTRATION; LEISHMANIA DONOVANI; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; VISCERAL LEISHMANIASIS;

ADOLESCENT; ADULT; AGED; ANTIMONY SODIUM GLUCONATE; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; HUMANS; LEISHMANIASIS, VISCERAL; MIDDLE AGED; PAROMOMYCIN; TREATMENT OUTCOME;

LEISHMANIA DONOVANI; NASO HEXACANTHUS;

EID: 0028969908     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1016/0035-9203(95)90503-0     Document Type: Article

References (18)

1. Arcamone, F., Bertazzoli, C., Buogo, A., Cassinelli, G. & Vige- vani, A. (1975). New studies in the field of aminoglycosidic aminocyclitol antibiotics. Panminerva Medica, 16, 9-24.
2. Berman, J. D. (1988). Chemotherapy for leishmaniasis: Biochemical mechanisms, clinical efficacy, and future strategies. Reviews of Infectious Diseases, 10, 560-586.
3. Chulay, J. D. & Bryceson, A. D. M. (1983). Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis. American Journal of Tropical Medicine and Hygiene, 32, 475-479.
4. Chunge, C. N., Owate, J., Pamba, H. O. & Donno, L. (1990). Treatment of visceral leishmaniasis in Kenya by aminosidine alone or combined with sodium stibogluconate. Transactions of the Royal Society of Tropical Medicine and Hygiene, 84, 221-225.
5. Edlind, T. D. (1991). Protein synthesis as a target for antiprotozoal drugs. In: Biochemical Protozoology, Coombs, G. H. & North, M. J. (editors). London & Washington, DC: Taylor & Francis, pp. 569-586.
6. India (1991). Report of the Expert Committee on Kala-Azar in Bihar. North Delhi: Directorate general of Health Services, Ministry of Health and Family Welfare, Government of India.
7. McCoy, N. G. & Neal, R. A. (1989). The effect of combinations of sodium stibogluconate with other antileishmanial agents against Leishmania donovani. Transactions of the Royal Society of Ttopical Medicine and Hygiene, 83, 428.
8. Neal, R. A. (1968). The effect of antibiotics of the neomycin group on experimental cutaneous leishmaniasis. Annals of Tropical Medicine and Parasitology, 62, 54-62.
9. Olliaro, P. L. & Bryceson, A. D. M. (1993). Practical progress and new drugs for changing patterns of leishmaniasis. Parasitology Today, 9, 323-328.
10. Peter, W. (1981). The treatment of kala-azar: New approaches to an old problem. Indian Journal of Medical Research, 73, supplement, 1-18.
11. Schilling, R. T. & Schaffner, C. P. (1961). Differentiation of catenulin-neomycin antibiotics: Identity of catenulin, paromomycin, hydroxymycin and aminosidine. Antimicrobial Agents and Chemotherapy, 4, 274-285.
12. Seaman, J., Pryce, D., Sondorp, H. E., Moody, A., Bryceson, A. D. & Davidson, R. N. (1993). Epidemic visceral leishma-niasis in Sudan: A randomized trial of aminosidine plus sodium stibogluconate versus sodium stibogluconate alone. Journal of Infectious Diseases, 168, 715-720.
13. Teklemariam, S., Hiwot, A. G., Frommel, D., Miko, T. L., Ganlov, G. & Bryceson, A. (1994). Aminosidine and its combination with sodium stibogluconate in the treatment of diffuse cutaneous leishmaniasis caused by Leishmaniaaethiopica. Transactions of the Royal Society of Tropical Medicine and Hygiene, 88, 334-339.
14. Thakur, C. P. (1984). Epidemiological, clinical and therapeutic features of Bihar kala-azar (including post kala-azar dermal leishmaniasis). Transactions of the Royal Society of Tropical Medicine and Hygiene, 78, 391-398.
15. Thakur, C. P. (1993). Diminishing effectiveness of currently used drugs in kala-azar and on the effect of amphotericin B in antimony and pentamidine resistant kala-azar. In: Current Trends in Leishmania Research, Blanduri, A. N., Basu, M. K., Sen, A. K. & Kumar, S. (editors). New Delhi: Council of Scientific and Industrial Research.
16. Thakur, C. P., Kumar, M., Kumar, P., Mishra, B. N. & Pan- dey, A. K. (1988). Rationalization of regimens of treatment of kala-azar with sodium stibogluconate in India: A randomized study. British Medical Journal, 296, 1557-1561.
17. Thakur, C. P., Kumar, R. & Pandey, A. K. (1991). Evaluation of efficacy of longer duration of therapy of fresh cases of kala- azar with sodium stibogluconate. Indian Journal of Medical Research, 93, 103-110.
18. Thakur, C. P., Olliaro, P., Gothoskar, S., Choudhury, B. K., Prasad, S., Kumar, M. & Verma, B. B. (1992). Treatment of visceral leishmaniasis (kala-azar) with aminosidine (=paromo- mycin)-antimonial compounds, a pilot study in Bihar, India. Transactions of the Royal Society of Tropical Medicine and Hygiene, 86, 615-616.